{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:59:33Z","timestamp":1777514373858,"version":"3.51.4"},"reference-count":26,"publisher":"Sociedade Brasileira de Cardiologia","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,3]]},"DOI":"10.36660\/abc.20190642","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T18:40:08Z","timestamp":1615401608000},"page":"395-401","source":"Crossref","is-referenced-by-count":11,"title":["Intera\u00e7\u00e3o Letal entre S\u00edndrome Hemofagoc\u00edtica e Insufici\u00eancia Card\u00edaca Recentemente Desenvolvida"],"prefix":"10.36660","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4557-3390","authenticated-orcid":false,"given":"Devrim","family":"Bozkurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukriye Miray Kilincer","family":"Bozgul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Emgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Butun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timur","family":"Kose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evrim","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9454-4521","authenticated-orcid":false,"given":"Mine","family":"Hekimgil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-3747","authenticated-orcid":false,"given":"Salih","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"2","key":"key20210310134002_B1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.revmed.2012.07.014","article-title":"Hemophagocytic lymphohistiocytosis","volume":"34","author":"Michot","year":"2013","unstructured":"1. Michot J, Hie M, Galicier L, Lambotte O, Michel M, Queyrat CB, et al. Hemophagocytic lymphohistiocytosis. Rev Med Interne. 2013; 34(2):85-93.","journal-title":"Rev Med Interne"},{"issue":"11","key":"key20210310134002_B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.amjcard.2005.03.006","article-title":"Immune activation in chronic heart failure","volume":"95","author":"Torre-Amione","year":"2005","unstructured":"2. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol. 2005;95(11):3-8.","journal-title":"Am J Cardiol"},{"issue":"11","key":"key20210310134002_B3","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","unstructured":"3. Mann DL,. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circulation. 2002; 91(11): 988-98.","journal-title":"Circulation"},{"issue":"5","key":"key20210310134002_B4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1388-9842(01)00156-8","article-title":"A glossary of circulating cytokines in chronic heart failure. European journal of heart failure","volume":"3","author":"Adamopoulos","year":"2001","unstructured":"4. Adamopoulos S, Parissis JT, Kremastinos DT. A glossary of circulating cytokines in chronic heart failure. European journal of heart failure. Eur J Heart Fail. 2001 Oct;3(5):517-26.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"key20210310134002_B5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","article-title":"Tumor necrosis factor-\u03b1 and tumor necrosis factor receptors in the failing human heart","volume":"93","author":"Torre-Amione","year":"1996","unstructured":"5. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, et al. Tumor necrosis factor-\u03b1 and tumor necrosis factor receptors in the failing human heart. Circulation. 1996 Feb 15;93(4):704-11.","journal-title":"Circulation"},{"issue":"5","key":"key20210310134002_B6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/euhj.1997.0858","article-title":"Systemic inflammation in patients with heart failure","volume":"19","author":"Hasper","year":"1998","unstructured":"6. Hasper D, Hummel M, Kleber FX, Reindl I, Volk HD. Systemic inflammation in patients with heart failure. Eur Heart J. 1998 May;19(5):761-5.","journal-title":"Eur Heart J"},{"issue":"3","key":"key20210310134002_B7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9149(98)00872-8","article-title":"Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"83","author":"Aukrust","year":"1999","unstructured":"7. Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, et al., Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1999 Feb 1;83(3):376-82.","journal-title":"Am J Cardiol"},{"issue":"12","key":"key20210310134002_B8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.CIR.97.12.1136","article-title":"Elevated circulating levels of CC chemokines in patients with congestive heart failure","volume":"97","author":"Aukrust","year":"1998","unstructured":"8. Aukrust Pl, Ueland T, Muller F, Andreassen AK, Nordoy I, Aas H, et al. Elevated circulating levels of CC chemokines in patients with congestive heart failure. Circulation. 1998 Mar 31;97(12):1136-43","journal-title":"Circulation"},{"issue":"1","key":"key20210310134002_B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00392-017-1170-6","article-title":"Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the \u201cHeart Failure Working Group\u201d of the German Society of Cardiology (DKG)","volume":"107","author":"Tschope","year":"2018","unstructured":"9. Tschope C, Birner C, Bohm M, Bruder O, Frantz S, Luchner A, et al. Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the \u201cHeart Failure Working Group\u201d of the German Society of Cardiology (DKG). Clin Res Cardiol. 2018 Jan;107(1):1-19.","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"key20210310134002_B10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","unstructured":"10. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012 Aug;14(8):803-69.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"key20210310134002_B11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","unstructured":"11. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007 Feb;48(2):124-31.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"key20210310134002_B12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","unstructured":"12. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"key20210310134002_B13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1744-9987.2012.01088.x","article-title":"Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis","volume":"16","author":"Hirakata","year":"2012","unstructured":"13. Hirakata H, Nitta K, Inaba M, Shoji T, Fujii H, Kobayashi S, et al. Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis. Ther Apher Dial. 2012 Oct;16(5):387-435.","journal-title":"Ther Apher Dial"},{"issue":"10","key":"key20210310134002_B14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jamacardio.2018.2568","article-title":"Association of natriuretic peptides with cardiovascular prognosis in heart failure with preserved ejection fraction: secondary analysis of the TOPCAT Randomized Clinical Trial","volume":"3","author":"Myhre","year":"2018","unstructured":"14. Myhre PL, Vaduganathan M, Clagget BL, Anand IS, Sweitzer NK, Fang JC, et al. Association of natriuretic peptides with cardiovascular prognosis in heart failure with preserved ejection fraction: secondary analysis of the TOPCAT Randomized Clinical Trial. JAMA Cardiol. 2018 Oct 1;3(10):1000-5.","journal-title":"JAMA Cardiol"},{"issue":"9","key":"key20210310134002_B15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan","year":"2017","unstructured":"15. Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017 Nov 1;29(9):401-9","journal-title":"Int Immunol"},{"issue":"2","key":"key20210310134002_B16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ajem.2016.10.055","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients","volume":"35","author":"Hwang","year":"2017","unstructured":"16. Hwang SY, Shin TG, Jo IJ, Jeon K, Suh GY, Lee TR, et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. Am J Emerg Med. 2017 Feb;35(2):234-9.","journal-title":"Am J Emerg Med"},{"key":"key20210310134002_B17","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3758068","article-title":"Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?","volume":"2018","author":"Djordjevic","year":"2018","unstructured":"17. Djordjevic D, Rondovic G, Surbatovic M, Stanojevic I, Udovicic I, Andjelic T, et al. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia? Mediators Inflamm. 2018 Jul 15;2018:3758068.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"key20210310134002_B18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5414\/CNP63022","article-title":"A low lymphocyte percentage is a predictor of mortality and hospitalization in hemodialysis patients","volume":"63","author":"Kuwae","year":"2005","unstructured":"18. Kuwae N, Kopple J, Kalantar-Zadeh K. A low lymphocyte percentage is a predictor of mortality and hospitalization in hemodialysis patients. Clin Nephrol. 2005 Jan;63(1):22-34.","journal-title":"Clin Nephrol"},{"issue":"3738","key":"key20210310134002_B19","article-title":"Adult onset haemophagocytic lymphohistiocytosis prognosis is affected by underlying disease: analysis of a single-institution series of 174 patients","volume":"148","author":"Zhang","year":"2018","unstructured":"19. Zhang Q, Li L, Zhu L, Zhu J, Yang X, Zhou D, et al. Adult onset haemophagocytic lymphohistiocytosis prognosis is affected by underlying disease: analysis of a single-institution series of 174 patients. Swiss Med Wkly. 2018;148(3738).","journal-title":"Swiss Med Wkly"},{"issue":"30","key":"key20210310134002_B20","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/eurheartj\/ehy301","article-title":"Heart failure with preserved ejection fraction: from mechanisms to therapies","volume":"39","author":"Lam","year":"2018","unstructured":"20. Lam CS, Voors AA, Boer RA, Solomon SD, Veldhuisen DJ. Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J. 2018 Aug 7;39(30):2780-92.","journal-title":"Eur Heart J"},{"issue":"19","key":"key20210310134002_B21","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMcp1511175","article-title":"Heart failure with preserved ejection fraction","volume":"375","author":"Redfield","year":"2016","unstructured":"21. Redfield MM. Heart failure with preserved ejection fraction. N Engl J Med. 2016 Nov 10;375(19):1868-77.","journal-title":"N Engl J Med"},{"issue":"2","key":"key20210310134002_B22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/SHK.0000000000001048","article-title":"Hemophagocytic lymphohistiocytosis: potentially underdiagnosed in intensive care units","volume":"50","author":"Lachmann","year":"2018","unstructured":"22. Lachmann G, Spies C, Schenk T, Brunkhorst FM, Balzer F, Rosee P. Hemophagocytic lymphohistiocytosis: potentially underdiagnosed in intensive care units. Shock. 2018 Aug;50(2):149-55.","journal-title":"Shock"},{"issue":"4","key":"key20210310134002_B23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10741-018-09768-9","article-title":"Cardiorenal syndrome in heart failure with preserved ejection fraction\u2014an under-recognized clinical entity","volume":"24","author":"Agrawal","year":"2019","unstructured":"23. Agrawal A, Naranjo M, Kanjanahattakij N, Rangaswami J, Gupta S. Cardiorenal syndrome in heart failure with preserved ejection fraction\u2014an under-recognized clinical entity. Heart Fail Rev. 2019 Jul;24(4):421-37.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"key20210310134002_B24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40560-019-0367-3","article-title":"A simplified definition of diastolic function in sepsis, compared against standard definitions","volume":"7","author":"Lanspa","year":"2019","unstructured":"24. Lanspa MJ, Olsen TD, Wilson EL, Leguyader ML, Hirshberg EL, Anderson JL, et al. A simplified definition of diastolic function in sepsis, compared against standard definitions. J intensive care. 2019. 7(1):14.","journal-title":"J intensive care"},{"issue":"2","key":"key20210310134002_B25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/CCM.0b013e3181feeb15","article-title":"Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality","volume":"39","author":"Boyd","year":"2011","unstructured":"25. Boyd JH, Forbes J, Nakada T, Walley KR, Russel JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011 Feb;39(2):259-65.","journal-title":"Crit Care Med"},{"issue":"9","key":"key20210310134002_B26","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","unstructured":"26. Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014 Sep;66(9):2613-20.","journal-title":"Arthritis Rheumatol"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/abccardiol.org\/article\/interacao-letal-entre-sindrome-hemofagocitica-e-insuficiencia-cardiaca-recentemente-desenvolvida\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:03:58Z","timestamp":1747400638000},"score":1,"resource":{"primary":{"URL":"http:\/\/abccardiol.org\/article\/interacao-letal-entre-sindrome-hemofagocitica-e-insuficiencia-cardiaca-recentemente-desenvolvida\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,3]]}},"alternative-id":["10.36660\/abc.20190642"],"URL":"https:\/\/doi.org\/10.36660\/abc.20190642","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}